Bryxta 400 Injection Bryxta 400 Injection Bryxta 400 Injection Bryxta 400 Injection Bryxta 400 Injection Bryxta 400 Injection Bryxta 400 Injection

Bryxta 400 Injection

9000.0 INR/VIAL

Product Details:

  • Origin of Medicine INDIA
  • Physical Form Liquid
  • Recommended For DOCTOR
  • Quantity 25 Pieces
  • Click to view more
X

Bryxta 400 Injection Price And Quantity

  • 9000.0 INR/VIAL
  • 25 Piece

Bryxta 400 Injection Product Specifications

  • DOCTOR
  • 25 Pieces
  • Liquid
  • INDIA

Bryxta 400 Injection Trade Information

  • 1 Week

Product Description

Bryxta 400 mg Injection is an advanced anti-cancer treatment that utilizes bevacizumab, a monoclonal antibody designed to inhibit the activity of vascular endothelial growth factor (VEGF), a protein that promotes tumor growth by facilitating the formation of blood vessels. This innovative medication is commonly prescribed in combination with other therapies for various cancers, including colon cancer, non-small cell lung cancer, glioblastoma, kidney cancer, and ovarian cancer. By targeting VEGF, Bryxta effectively disrupts the blood supply to tumors, potentially slowing their growth and progression. Patients receiving this treatment should be aware of potential side effects, including an increased risk of bleeding, gastrointestinal perforations, and hypertension, making regular monitoring essential. As with any cancer therapy, discussing your medical history and any pre-existing conditions with your healthcare provider is crucial to ensure the safest and most effective treatment plan. Bryxta 400 mg Injection represents a significant advancement in oncological care, providing hope for those battling various malignancies. Always consult with your oncologist to determine if Bryxta is the right choice for your specific cancer treatment regimen.
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Injection' category



Back to top